ClinicalTrials.gov
ClinicalTrials.gov Menu

Switch From Nevirapine-based Regimen to Once a Day Rilpivirine/Emtricitabine/Tenofovir (Near-Rwanda)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02104700
Recruitment Status : Unknown
Verified July 2015 by Philip Grant, Stanford University.
Recruitment status was:  Active, not recruiting
First Posted : April 4, 2014
Last Update Posted : July 16, 2015
Sponsor:
Collaborators:
Rwanda Biomedical Center
Gilead Sciences
Information provided by (Responsible Party):
Philip Grant, Stanford University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : May 2016
  Estimated Study Completion Date : July 2016